Search research articles
Contact Us
Filters
Showing results (391-400 of 509) with videos related to
Page
of 51
Sort By:
Antiviral Therapy
|
December 1, 2005
Predictors of hypertension and changes of blood pressure in HIV-infected patients
Rodolphe Thiébaut, Wafaa M El-Sadr, Nina Friis-Møller, et al.
Journal of the International AIDS Society
|
August 9, 2024
Assessing the HIV care continuum among transgender women during 11 years of follow-up: results from the Netherlands' ATHENA observational cohort
Vita W Jongen, Ceranza Daans, Ard van Sighem, et al.
Lancet (London, England)
|
April 5, 2008
Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration
, Caroline A Sabin, Signe W Worm, et al.
The Journal of Infectious Diseases
|
July 9, 2020
The Impact of Immunosuppression on Chronic Kidney Disease in People Living With Human Immunodeficiency Virus: The D:A:D Study
Lene Ryom, Jens D Lundgren, Peter Reiss, et al.
Nature Communications
|
April 22, 2025
Model-based evaluation of the impact of a potential HIV cure on HIV transmission dynamics
Alfredo De Bellis, Myrthe S Willemsen, Giorgio Guzzetta, et al.
The New England Journal of Medicine
|
November 25, 2003
Combination antiretroviral therapy and the risk of myocardial infarction
Nina Friis-Møller, Caroline A Sabin, Rainer Weber, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
August 12, 2016
Difference in Aortic Stiffness Between Treated Middle-Aged HIV Type 1-Infected and Uninfected Individuals Largely Explained by Traditional Cardiovascular Risk Factors, With an Additional Contribution of Prior Advanced Immunodeficiency
Katherine W Kooij, Judith Schouten, Ferdinand W N M Wit, et al.
AIDS (London, England)
|
February 1, 2024
Specific plasma microRNAs are associated with CD4 + T-cell recovery during suppressive antiretroviral therapy for HIV-1
Stefanie Kroeze, Neeltje A Kootstra, Ad C van Nuenen, et al.
The Lancet. HIV
|
November 2, 2015
Bone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with either raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with HIV-1: a substudy of the NEAT001/ANRS143 randomised trial
Jose I Bernardino, Amanda Mocroft, Patrick W Mallon, et al.
Plos Medicine
|
November 5, 2004
Nevirapine and efavirenz elicit different changes in lipid profiles in antiretroviral-therapy-naive patients infected with HIV-1
Frank van Leth, Prahpan Phanuphak, Erik Stroes, et al.
Page
of 51
Search research articles
Search
Showing results (391-400 of 509) with videos related to
Sort By:
Page
of 51
Antiviral Therapy
|
December 1, 2005
Predictors of hypertension and changes of blood pressure in HIV-infected patients
Rodolphe Thiébaut, Wafaa M El-Sadr, Nina Friis-Møller, et al.
Journal of the International AIDS Society
|
August 9, 2024
Assessing the HIV care continuum among transgender women during 11 years of follow-up: results from the Netherlands' ATHENA observational cohort
Vita W Jongen, Ceranza Daans, Ard van Sighem, et al.
Lancet (London, England)
|
April 5, 2008
Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration
, Caroline A Sabin, Signe W Worm, et al.
The Journal of Infectious Diseases
|
July 9, 2020
The Impact of Immunosuppression on Chronic Kidney Disease in People Living With Human Immunodeficiency Virus: The D:A:D Study
Lene Ryom, Jens D Lundgren, Peter Reiss, et al.
Nature Communications
|
April 22, 2025
Model-based evaluation of the impact of a potential HIV cure on HIV transmission dynamics
Alfredo De Bellis, Myrthe S Willemsen, Giorgio Guzzetta, et al.
The New England Journal of Medicine
|
November 25, 2003
Combination antiretroviral therapy and the risk of myocardial infarction
Nina Friis-Møller, Caroline A Sabin, Rainer Weber, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
August 12, 2016
Difference in Aortic Stiffness Between Treated Middle-Aged HIV Type 1-Infected and Uninfected Individuals Largely Explained by Traditional Cardiovascular Risk Factors, With an Additional Contribution of Prior Advanced Immunodeficiency
Katherine W Kooij, Judith Schouten, Ferdinand W N M Wit, et al.
AIDS (London, England)
|
February 1, 2024
Specific plasma microRNAs are associated with CD4 + T-cell recovery during suppressive antiretroviral therapy for HIV-1
Stefanie Kroeze, Neeltje A Kootstra, Ad C van Nuenen, et al.
The Lancet. HIV
|
November 2, 2015
Bone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with either raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with HIV-1: a substudy of the NEAT001/ANRS143 randomised trial
Jose I Bernardino, Amanda Mocroft, Patrick W Mallon, et al.
Plos Medicine
|
November 5, 2004
Nevirapine and efavirenz elicit different changes in lipid profiles in antiretroviral-therapy-naive patients infected with HIV-1
Frank van Leth, Prahpan Phanuphak, Erik Stroes, et al.
Page
of 51